Immuneering (IMRX) Share-based Compensation (2020 - 2024)
Historic Share-based Compensation for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to $1.7 million.
- Immuneering's Share-based Compensation rose 512.96% to $1.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.5 million, marking a year-over-year increase of 1351.86%. This contributed to the annual value of $6.5 million for FY2024, which is 1351.86% up from last year.
- As of Q4 2024, Immuneering's Share-based Compensation stood at $1.7 million, which was up 512.96% from $1.6 million recorded in Q3 2024.
- In the past 5 years, Immuneering's Share-based Compensation registered a high of $1.7 million during Q4 2024, and its lowest value of $182225.0 during Q1 2021.
- Its 5-year average for Share-based Compensation is $995273.5, with a median of $1.1 million in 2022.
- In the last 5 years, Immuneering's Share-based Compensation surged by 39260.53% in 2022 and then soared by 512.96% in 2024.
- Over the past 5 years, Immuneering's Share-based Compensation (Quarter) stood at $216607.0 in 2020, then surged by 192.04% to $632583.0 in 2021, then surged by 65.7% to $1.0 million in 2022, then soared by 56.52% to $1.6 million in 2023, then rose by 5.13% to $1.7 million in 2024.
- Its last three reported values are $1.7 million in Q4 2024, $1.6 million for Q3 2024, and $1.7 million during Q2 2024.